Dr Ravindhi Murphy retweeted
Strong @ChelwestFT team representation at #ESMO25 this year
Congratulations to Claire, Chloe & Kyle for their first ESMO posters
👊
Dr Ravindhi Murphy retweeted
This is probably the most important publication we have published for trainees and senior oncologists alike. This provides answers to almost every question you have about surrogate endpoints in oncology. This is a must-read for anyone with an interest in cancer trials. FREE!
Our brilliant @ChelwestFT ADOC team were delighted to be recognised by the @RMPartnersNHS rapid diagnostic clinic celebration day. The first clinic of its kind to be developed for investigating patients with vague symptoms to diagnose cancer. Earlier diagnosis improves outcomes!
Dr Ravindhi Murphy retweeted
Metastatic colorectal cancer. Third line and beyond. How to treat and what's the evidence. Nice review in @NatRevClinOncol
Dr Ravindhi Murphy retweeted
Attention #BCSP centres! We have created an SOP for the use of aspirin in #LynchSyndrome patients attending for #colonoscopy … please send me a message if you would like a copy - thanks! @stmarksbcsc @LynchSyndromeUK @StMarksGenomics @BowelsOfStMarks @NHSEngland
Dr Ravindhi Murphy retweeted
We have 2 trials of bispecific antibodies in lung cancer open and running @ChelwestFT
In fact, recruited the first patients in Europe to both of these
🦸
Bispecific antibodies (bsAbs) allow therapeutic applications that cannot be achieved using conventional antibodies. There are 14 bsAbs approved: 11 for cancer & 3 for non-oncology indications. This review summarizes this very active field, including bsAb signaling pathway modulators, tumor-targeted receptor agonists, ADC, bispecific T cell, natural killer cell & checkpoint inhibitors.nature.com/articles/s41573-0…
Dr Ravindhi Murphy retweeted
Liver transplantation + CTx vs CTx in unresectable CRC liver metastases
🔎TransMet randomised trial
@TheLancet
doi.org/10.1016/S0140-6736(2…
👉5-yr OS: 56.6 vs 12.6%
👉Recurrence after LTx: 72%
🧐Impressive study, impressive results
❗️LTx valid option in highly selected pts
@myESMO @EASLedu @ILCAnews #livertwitter
Great to share our data & generate discussion around management of malignant bowel obstruction @myESMO . Data collected from the @WestMidHospital @ChelwestFT AOS team highlighting need for MDT involvement and national guidelines to improve patient care and experience #ESMO2024
Malignant bowel obstruction: from outstanding @WestMidHospital AOS team
❗️24% died during admission
❗️74% had no further SACT
❗️Only 50% referred to palliative care
👉 Need MDT discussion for every case
👉 Need national guidelines for best management
#ESMO2024
Great to join @Cancer52org at the #bigcancer52conversation today, talking about the DETERMINE clinical trial which is open for patients of all ages with rare cancer across the ECMC network @CR_UK @ECMC_UK
Dr Ravindhi Murphy retweeted
With the rising incidence of #colorectal #cancer (particularly in younger adults) this really is a ‘tidal wave’ of a response curve - can’t wait for the phase 3 RCT!
@kevinjmonahan @bowelcanceruk @bhmullish @PaulKMiddleton @ravindhi
Ecstatic and proud to share the NICHE-2 results, now published in @NEJM. Out of 111 pts, 95% had an MPR , and 68% a pCR after only 4 weeks of #neoadjuvant #immunotherapy. Grateful to the pts and colleagues who made this possible. @HaanenJohn
nej.md/3Ku4X0H
Joe's story themulberrycentre.enthuse.co… After emergency surgery and 18 cycles of chemotherapy, Joe is running to raise money for @MulberryCentre on his chemo break. What an incredible person living with bowel cancer and such a worthy cause to support. Please consider donating!
Nice to see some of our @ChelwestFT ADOC data being shared at #BTOG24. Our RDC has a brilliant team of GPs, nurses and consultants to improve faster diagnosis of cancer in patients with complex and vague symptoms
Proud to see @ChelwestFT Rapid Diagnostic Clinic data presented at #BTOG24
👉 Lung is commonest cancer diagnosed
👉 RDC presentation associated with older age, complex symptoms & raised inflammatory markers
👉 RDCs import patent in presentation of lung cancer
#LCSM #BTOG24
Dr Ravindhi Murphy retweeted
A smokefree future could mean tens of thousands fewer cancer deaths each year in the UK.
Read more about why today's tobacco Age of Sale legislation is important, including thoughts from our Executive Director @IanWalker_CRUK 👇 bit.ly/44h9eOl
#SmokefreeUK
Delighted to head to Westminster today to support @Cancer52org manifesto for rare cancers. We are passionate about supporting patients with rare cancers and improving outcomes. We hope many of them will be involved with the DETERMINE trial running across the UK @ECMC_UK @CR_UK
Dr Ravindhi Murphy retweeted
I am at a terrific panel on women's health as part of my Corpus Christi College's truly inspiring 40 years of women in the college plus International Women's Day celebration. @ravindhi Speaking about the importance of @bowelbabe in increasing bowel cancer screening.
Dr Ravindhi Murphy retweeted
🎉 We are thrilled to welcome Gary Middleton as the new ECMC network lead.
We caught up with Gary to find out his plans for his first year, and his thoughts on some key challenges faced by the #Cancer research sector. Read his thoughts👉 rb.gy/ty7gfz
A very interesting read for anyone working in drug development and/or oncology
Power, money & cancer medicines. A reality check. ecancer.org/en/journal/edito…
Dr Ravindhi Murphy retweeted
Cervical cancer will be almost eliminated in coming decades if HPV vaccination rates are high in children.
In England HPV vaccination coverage in schools is rising again but still below pre-pandemic levels. Please encourage children to get protected.
gov.uk/government/statistics…
Dr Ravindhi Murphy retweeted
I don't know who needs to know this more ( oncologist or patients or both ) But this is one of the best piece about cancer and diet misinformation in @TheLancetOncol.
Say NO to ketogenic diets , alkaline diets as treatment options.
Say NO to Quackery .

































